Senior Physician, Hypertension Unit
Department of Medicine
Hadassah University Hospital
Mount Scopus, Jerusalem.
Telephone: 972-2-5790659.
Fax: 972-2-5844705
E-mail: bursz@cc.huji.ac.il;
1952 Born in Warsaw, Poland.
1957 Immigrated with family to Israel.
1970-1973 Military Service, Israel Defense Forces.
Marital Status: Married, three children.
Citizenship: Israeli.
Home Address: 14 Odem Street, Mevasseret-Zion 90805, Israel.
1974-1980 Hebrew University-Hadassah Medical School, Jerusalem. Recipient of prizes for scholarship from the Hebrew University, Jerusalem.
1981 Visa Qualifying Examination (VQE).
1981-1982 Intern, Rambam Medical Center, Haifa.
1982 Degree granted: M.D.
1982-1987 Training in Internal Medicine, Chaim Sheba Medical Center at Tel Hashomer, Israel.
1987 Specialist Certificate 09311 in Internal Medicine.
1987-1989 Research Fellow, Cardiovascular Institute, Boston University School of Medicine, Boston, U.S.A.
1989 Senior Physician, Hypertension Unit, Department of Medicine, Hadassah University Hospital on Mount Scopus, Jerusalem.
01.02.90 Lecturer in Medicine, Hebrew University-Hadassah Medical School, Jerusalem.
03.07.94 Senior Lecturer in Medicine, Hebrew University-Hadassah Medical School, Jerusalem.
03.07.94 Visiting Scientist, Hypertension and Atherosclerosis. Section, Whitaker Cardiovascular Institute, Boston. University School of Medicine, Boston, U.S.A. Clinical Hypertension Specialist of the European Society of Hypertension
02.082001 Associate Professor of Medicine, Hadassah University Hospital-Hebrew University Medical School, Jerusalem.
27.09.2001 Fellow of the American Heart Association F.A.H.A
Membership of Committees
1991 Organizing Committee of The Israel Hypertension Society Meeting.
1994 Organizing Committee Fifth International Symposium on Hypertension in the Community.
1994-1995 Committee of Hypertension, National Councils for Prevention and Treatment of Cardiovascular Diseases. Sub-Committee on Anti-Hypertensive Drugs of the Sick Fund's Central Drug Committee.
1996 Hypertension Program Committee of the 34th European Renal Association. European Dialysis and Transplantation Association.
1997 International Fellow, High Blood Pressure Research Council, American Heart Association. Scientific Council, Israel Society of Hypertension. Hadassah University Hospitals’ Formulary Committee.
International Advisory Board of the Seventh International Symposium on Hypertension in the Community. Institutional Medical Quality Committee, Hadassah University Hospitals.
National Councils of Health, committee for cardiovascular disease prevention.
Teaching Experience
1982-1987 Teaching medical students during their 4th-6th years Internal Medicine clerkship, Tel Aviv University, Sackler Faculty of Medicine, Tel Aviv, Israel.
1987-1989 Teaching medical students during their 3rd-4th years electives in the Hypertension Section, and in the Biology of Disease Course on Cardiovascular Diseases, Boston University School of Medicine, Boston, U.S.A.
1989 Teaching medical students during their 4th-6th years Internal Medicine clerkship, Hebrew University-Hadassah Medical School, Jerusalem, Israel.
1998-1999 Mentor of students’ M.D. thesis of the Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Dr. Amit Korach: “Correlates of Hypertension in the 70 Year Olds Longitudinal Study”. Dr. Ofra Spillberg: “Prevalence, Awareness, Treatment and Control in the 70 Year Olds Longitudinal Study”.
Invited Lectures
1992 Insulin Resistance and Hypertension. Medical Grand Rounds, Barzilay Medical Center, Ashkelon.
1992 Exercise Training and Blood Pressure Control. Medical Grand Rounds, Shaare Zedek Medical Center, Jerusalem.
1992 Insulin and Hypertension in Ethiopian Immigrants. Endocrinology Institute, Tel Aviv Medical Center, Tel Aviv.
1993 Insulin Resistance and Hypertension in Man and Rat. Department of Endocrinology, Hadassah University Hospital, Jerusalem.
1993 Detection, Evaluation and Treatment of Hypertension. General Sick Fund Physicians' Update, Maale Hachamisha.
1994 Importance of Hypertension Control in Diabetic Patients. Maccabi Sick Fund Physicians' Update, Kfar Hamaccabia, Ramat Gan.
1994 Hypertension in Pregnancy. Symposium on Medical Complications of Pregnancy, Shaare Zedek Medical Center, Jerusalem.
1994 Are Day and Night Sleep Equivalent? Ambulatory Blood Pressure Monitoring Study. The 1st Scientific Meeting of the Egyptian Hypertension League, Sharm El Sheikh.
1995 Role of Hypertension in Diabetic Complications. Meuchedet Sick Fund Physicians' Update, Jerusalem.
1995 Role of Insulin in Hypertension. Satellite Symposium to the 7th European Meeting on Hypertension, "Metabolic Disturbances in Hypertension", Gdansk, Poland.
1995 The Siesta and Ambulatory Blood Pressure. Endocrinology Institute, Tel Aviv Medical Center, Tel Aviv.
1996 Blunted Blood Pressure Decline in Pregnant Hyperinsulinemic Rats: A Role of Nitric Oxide? Whitaker Cardiovascular Institute Lecture Series, Boston University School of Medicine, Boston, U.S.A.
1997 Anesthesia and Blood Pressure Control. The 2nd International Symposium on Perioperative Cardiac Care, Tel Aviv.
1998 Detection, Evaluation and Treatment of Hypertension. Update Course of the Department of Family Medicine, Hebrew University-Hadassah Medical School, Jerusalem.
1998 Joint National Committee VI: Guidelines on The Management of High Blood Pressure. Continuous Medical Education Course (CME) in Adult Medicine of the Department of Family Medicine, Faculty of Health Sciences, Ben Gurion University, Beer Sheba.
1998 Amelioration of Rat Hyperinsulinemic Pregnancy Induced Hypertension and Its Adverse Fetal Outcome by L-Arginine. Department of Obstetrics and Gynecology, Hadassah University Hospital, Jerusalem.
1998 Modern Treatment of High Blood Pressure: Role of Old-Fashioned Drugs. The 3rd Israel Congress of General Practice Family Medicine, Jerusalem.
1998 Role of Insulin in Hypertension. Israel French Binational Nephrology Meeting, Kibbutz Ginossar.
1998 Hypertension Update for Nephrology Fellows. Shefayam.
1999 Insulin and Hypertension. Hypertension for Graduate Students in Medical Sciences, Tel Aviv University, Tel Aviv.
1999 The Effect of The Siesta on Ambulatory Blood Pressure and Mortality in The Elderly. Mount Sinai End Organ Damage in Hypertension Seminar, Mount Sinai School of Medicine, New York, U.S.A.
1999 The Effect of The Siesta on Ambulatory Blood Pressure and Mortality in The Elderly. Endocrine-Hypertension Seminar, Brigham and Women’s Hospital, Boston, Massachusetts, U.S.A.
1999 The Effect of The Siesta on Ambulatory Blood Pressure and Mortality in The Elderly. Endocrine Seminar, Indiana University School of Medicine, Indianapolis, Indiana, U.S.A.
1999 The Siesta and Mortality in The Elderly. Scientific Meeting, Israel Geriatric Society Meeting, Kfar Hamaccabia, Ramat Gan.
2000 Insulin and Hypertension. Hypertension for Graduate Students in Medical Science. Tel Aviv University.
2000 Does Insulin Resistance Lead to Hypertension. Joint Symposium on “Endocrine Hypertension” of the Endocrine Israel Society and the Israel Society of Hypertension, Herzliya.
2000 Is There A Crosstalk between At1 and AT2 Receptors? New Insights from Contemporary Research. Jerusalem’s General Sick Fund Endocrinologists Meeting, Jerusalem.
2000 Blood Pressure, Daytime Sleep and Nocturnal Urination – Consequences to 24-Hour Ambulatory Blood Pressure Monitoring. Department of Psychiatry University of California, San Diego, U.S.A.
2000 Chronic Hyperinsulinemia in Pregnant Rats. A New Model of Pregnancy-Induced Hypertension. Sansum Research Institute, Santa Barbara, U.S.A.
2000 Nephrology Grand Rounds: Interactions of Insulin with Pregnancy and Nitric Oxide to Produce Hypertension in Rats. University of California, Davis, U.S.A.
2000 Insulin and Nitric Oxide. Berlex Company, Richmond, U.S.A.
2000 Is The Siesta Dangerous? The Dr. Elizabeth Podkaminer Memorial Lecture, General Sick Fund, Jerusalem.
2000 The Role of 24-Hour Ambulatory Blood Pressure Monitoring in Evaluating Drug Resistant Hypertension. A Special Joint Symposium, Israel Society of Hypertension and Association of Family Practice, Tel Aviv.
2001 Why is It So Difficult to Control Hypertension in Diabetics? A Joint Symposium of The Israel Societies of Hypertension, Atherosclerosis, Cardiology, Preventive Cardiology and Diabetes, Jerusalem.
2001 Interaction between Endothel and Insulin Produce Hypertension in Rats. Cardiology Seminar, Department of Cardiology, Hadassah University Hospital Ein Kerem, Jerusalem.
2001 Type II Diabetes Mellitus and Hypertension. Workshop on Type II Diabetes Mellitus of Maccabi Sick Fund, Herzliya.
Hypertension in Diabetes Focus on Angiotensin II Receptor Blockers. A Joint Symposium of The Israel Societies of Hypertension, Diabetes and Nephrology, Jerusalem.
2001 Conditions when insulin may elevate blood pressure. Faculty of Medicine monthly research lecture. Hebrew-University Hadassah school of medicine. Jerusalem.
2002 Sleep and blood pressure. Endocrine grand rounds. Institute of Endocrinology. Tel-Aviv medical center. Tel-Aviv.
2002 Does weight reduction lower blood pressure? Yes it does! Debate at the spring meeting of the Israel Society of Hypertension. Haifa.
2002 pre-“LIFE” reality. Mile stones in antihypertensive therapy. A Jerusalem Cardiovascular Forum. Jerusalem, Israel.
2002 Effect of the siesta on ambulatory blood pressure and mortality in the elderly. Effect of rest without sleep. Department of Population Health Sciences. University of Wisconsin Medical School. Madison, Wisconsin. USA.
2002 Cardiology grand rounds: Effect of the siesta on ambulatory blood pressure and mortality in the elderly. Effect of rest without sleep. University of California, Davis, U.S.A.
2002 Israel Society of Hypertension consenssus meeting on the role of angiotensin II Receptor blockers . Quesaria, Israel.
2002 Israel Society of Nephrology, 2nd symposium on phosphor, calcium and cardiac calcification: Effect of mild renal dysfunction on progression of coronay artery calcification. Insights from the insight study. Haifa, Israel.
2002 Medical grand rounds; Ambulatory blood pressure monitoring, use and insights. Sha’are Zadek medical center. Jerusalem, Israel.
2002 Hypertension Round Table. 14th Annual Meeting of the Mediterranean Association of Cardiology and Cardiac Surgery. Rhodes, Greece.
2002 The siesta, blood pressure and cardiovascular endpoints. 17th Annual Meeting of the Polish Society of Hypertension. Poznan, Poland.
2002 Is daytime sleep as dangerous as nocturnal sleep? United states-Israel
Solidarity Medical Conference/ CJP-Hadassah, Jerusalem, Israel.
2003 Cardiology Seminar: siesta as anew cardiovascular risk factor. Department of Cardiology, Hadassah University Hospital, Ein-Kerem, Jerusalem, Israel.
2003 Diuretics-first step therapy or obligatory component? Meeting of the Israel Society of Hypertension: Impacts of the ALLHAT results on antihypertensive therapy. Tel-Aviv. Israel.
2003 Nephrology ground rounds: Mild renal dysfunction as a risk factor for coronary disease. University of California, Davis, U.S.A.
2003 Israel Heart Society Scientific Meeting on Hypertension: Hypertension with diabetes mellitus and dyslipidemia- a case study. Dead-Sea Hyatt Regency, Isarel.
2003 Hypertension Working Group Meeting of the Israel Society of Nephrology and Hypertension: Ambulatory blood pressure monitoring in renal patients. Dead-Sea Golden Tulip Hotel, Israel.
2003 Update on calcium channel blockers in antihypertensive therapy. Family Medicine Teaching Forum. Hebrew University , Givat-Ram, Jerusalem, Israel.
For List of Publications, please see: PubMed
Non-Peer-Reviewed Papers
Bursztyn M, Gavras I, Gavras H. Quinapril: Mechanism of action, safety and effectiveness. Internal Medicine for The Specialist 10:79-85, 1989.
Bursztyn M. Management of renovascular hypertension: Regional considerations in the treatment of renovascular hypertension. Drugs Therap Perspect 2:11-12, 1993.
Chapters in Books
Bursztyn M, Grossman E, Rosenthal T. Moderate and severe hypertension treated with nifedipine tablets. In: Lichtlen PR (ed). New Therapy of Ischemic Heart Disease and Hypertension. 6th International Adalat Symposium. Excerpta Medica, Amsterdam, pp 487-491, 1986.
Shamis A, Grossman E, Bursztyn M, Rosenthal T. Nisoldipine: A replacement therapy for nifedipine and other vasodilators in the treatment of moderate to severe hypertension. In: Omae T, Zanchetti A (eds). How Should Elderly Patients be Treated? Springer Verlag, Tokyo, pp 227-231, 1989.
Bursztyn M, Gavras H. Clinical aspects of oral angiotensin converting enzyme inhibitors. In: Saito H, Minami M, Parvez SH (eds). Progress in Hypertension, Vol 2. VSP Press, Utrecht, Holland, pp 107-129, 1992.
Bursztyn M, Ben-Ishay D, Gutman A. Hyperinsulinemia and decreased deoxyglucose uptake in SHR but not in secondary hypertension. In: Sassard J (ed). Genetic Hypertension. John Libbey Eurotext, London, pp 385-387, 1992.
Bursztyn M . Diagnosis of Hypertension: Role of 24-hour Ambulatory and home bood pressure monitoring. In: Grossman E (ed) High blood pressure, diagnosis and therapy. Aurora Group, Tel-Aviv, pp 8-11,2001.(Hebrew)
Other Publications
Bursztyn, M, Bernheim J, Paran E, Viskoper R, Weissgarten Y, Yagil Y, Podjarny E, Fidel J, Kisch E, Rosenfeld J. Clinical Guidelines 2000: Diagnosis, follow-up and treatment of hypertension. The Israeli Society of Hypertension, The Israel Medical Association.
Oren S, Bursztyn, M, Ben-Shitrit S, Bernheim J, Gavish D, Goldbourt U, Goldhaber A, Golan A, Grossman G, Dicker D, Holtzman E, Weissgarten Y, Viskoper R, Vered Z, Zevin D, Traub Y, Yagil Y, Yodfat Y, Leshem Y, Markovitch A, Paran E, Zimmlichman R, Rosenfeld JB, Stern N, Sharabi Y. Updated guidelines for diagnosis and treatment of hypertension 11/2003.
Abstracts
1. Bursztyn M, Grossman E, Rosenthal T. Nifedipine in the treatment of essential renal and renovascular hypertension. Proceedings of the 5th Mediterranean Symposium on Calcium Antagonists. Jerusalem, October 1984.
2. Bursztyn M, Grossman E, Rosenthal T. Nifedipine tablets in hypertensives with concurrent diseases. Proceedings of the 5th Asian Congress of Cardiology. Bangkok, November 1984.
3. Bursztyn M, Grossman E, Rosenthal T. Moderate and severe hypertension treated with nifedipine tablets. Proceedings of the 6th International Adalat Symposium. Geneva, April 1985.
4. Bursztyn M, Grossman E, Rosenthal T. Nifedipine tablets in the treatment of renovascular hypertension. Proceedings of the Cardiovascular Phamacotherapy International Symposium. Geneva, April 1985.
5. Bursztyn M, Gavras I, Boger R, Glassman H, Luther R, Gavras H. Dissociation between plasma renin inhibition and blood pressure response to a renin inhibitor in hypertensive patients. Hypertension 12:341, 1988.
6. Bursztyn M, Gavras I, Bauer JH, Melby JC, Tifft CP, Boger R, Luther R, Gavras H. Renin inhibition in essential hypertension effect on angiotensin II and aldosterone. Clin Res 37:522A, 1989.
7. Bursztyn M, Bresnahan M, Gavras I, Gavras H. Platelet a-2-receptor numbers diminish with age: Down regulation by norepinephrine? Clin Res 37:331A, 1989.
8. Bursztyn M, Bresnahan M, Gavras I, Gavras H. Platelet -2-receptors, plasma norepinephrine, epinephrine and vasopressin in elderly black versus elderly white hypertensives and normotensive subjects. Clin Res 37:552A, 1989.
9. Bursztyn M, Bresnahan M, Gavras I, Gavras H. Age dependent decrease of a-2-receptors on human platelets. Proceedings of the 46th Annual Scientific Meeting of the American Geriatric Society/10th Annual Meeting of the American Federation of Aging Research. Boston, May 1989.
10. Bursztyn M, Bresnahan M, Gavras I, Gavras H. Differences of platelet a-2-receptor affinity, plasma epinephrine and vasopressin in black versus white elderly. Hypertension 13:509, 1989.
11. Bursztyn M, Gavras I, Tifft CP, Bauer JH, Melby JC, Gavras H. Renin inhibition: Effects on blood pressure and hormonal responses in man. Proceedings of the 4th European Meeting on Hypertension. Milan, June 1989.
12. Bursztyn M, Ben-Ishay D, Gutman A. Evidence of insulin resistance in primary but not in secondary hypertension of the rat. Am J Hypertens 4:120A, 1991.
13. Bursztyn M, Ben-Ishay D, Gutman A. Insulin sensitivity of epididymal fat of rats with primary and secondary hypertension. Am J Hypertens 4:120A, 1991.
14. Bakris GL, Bursztyn M, Gavras I, Bresnahan M, Gavras H. Pressor role of vasopressin in black hypertensives. Hypertension 18:378, 1991.
15. Raz I, Bursztyn M. Blood pressure rises in Ethiopian immigrants to Israel in parallel with their insulin level and response to oral glucose. Proceedings of the 4th International Symposium on Hypertension in The Community. Jerusalem, March 1992.
16. Bursztyn M, Mekler J, Ben-Ishay D. Vanadate induced salt sensitive hypertension. Am J Hypertens 5:78A, 1992.
17. Bursztyn M, Ben-Ishay D, Mekler J, Raz I. Chronic exogenous hyperinsulinemia and blood pressure in regular Sabra rats. Hypertension 20:410, 1992.
18. Bursztyn M, Mekler J, Wachtel N, Ben-Ishay D. The siesta and ambulatory blood pressure: Equivalence of the afternoon nap and night sleep. Am J Hypertens 6:121A, 1993.
19. Bursztyn M, Ben-Ishay D, Mekler J, Raz I. Chronic exogenous hyperinsulinemia is associated with acute salt-sensitive hypertension and renal dysfunction in regular Sabra rats. Proceedings of XIIth International Congress of Nephrology, Jerusalem, Israel, June 13-18, 1993.
20. Bursztyn M, Mekler J, Raz I, Ben-Ishay D. Calcium channel blockade improves glucose tolerance and enhances heart and muscle [3H]-deoxyglucose uptake in SHR. Hypertension 22:449, 1993.
21. Bursztyn M, Raz I, Mekler J, Ben-Ishay D. Chronic exogenous hyperinsulinemia accelerates the development of hypertension in SHR. Clin Exp Pharmacol Physiol (Suppl 1):S44, 1994.
22. Bursztyn M, Raz I, Mekler J, Ben-Ishay D. Insulin induced renal dysfunction in regular Sabra rats. Clin Exp Pharmacol Physiol (Suppl 1):S48, 1994.
23. Bursztyn M, Raz I. Longitudinal observations in blood pressure, glucose, insulin and lipids in Ethiopian immigrants. Am J Hypertens 18:34A, 1995.
24. Bursztyn M, Mekler J, Ben-Ishay D. The siesta and ambulatory blood pressure: Different hemodynamics of the morning and afternoon waking. Am J Hypertens 18:164A, 1995.
25. Bursztyn M, Raz I, Mekler J, Ben-Ishay D. Effect of acute L-NAME hypertension on gluccose tolerance, insulin levels and [3H]-deoxyglucose tissue uptake. Circulation 92 (Suppl I):I-155, 1995.
26. Bursztyn M, Mekler J, Ben-Ishay D. The siesta and ambulatory blood pressure in diabetic hypertensives: Attenuated decline during day and night time sleep. J Hypertens 14 (Suppl 1):S-181, 1996.
27. Bursztyn M, Podjarny E, Bernheim J. Chronic hyperinsulinemia in pregnancy. A rat model of pregnancy induced hypertension. Am J Hypertens 10:12A, 1997.
28. Bursztyn M, Oigman W, Stephens JD, Tilvis R, Kobrin I. Mibefradil in elderly hypertensives: Favorable hemodynamics and pharmacokinetics. Am J Hypertens 10:81A, 1997.
29. Bursztyn M, Yagil C, Yagil Y, Mekler J, Ben-Ishay D. Insulin increases blood pressure in hypertension-prone but not in hypertension-resistant rats. Clin ExpPharmacol Physiol 25;A23, 1998.
30. Bursztyn M, Ginsberg G, Spillberg O, Maaravi Y, Stessman Y. Mortality in the Jerusalem 70-year-olds study. A role of nifedipine? American Geriatrics Society 19th Annual Meeting, Seattle, May 1998.
31. Distefano A, Gavras H, Bursztyn M, Gavras I, Handy DE, Joost O, Nicolaou M, Streeten D, Schwartz F, Farrer LA, Baldwin CT. Localization of a gene for blood pressure regulation to human chromosome 18q. Am J Hypertens 11:5A, 1998.
32. Bursztyn M, Bernheim J, Rashed G, Podjarny E. L-arginine prevents pregnancy-induced hypertension in rats with chronic hyperinsulinemia. Hypertension 32:621, 1998.
33. Bursztyn M, Weiss O, Mekler J, Raz I. Atrophy or hypertrophy in two or one kidney Goldblatt models. Role of insulin-like growth factor I system? Hypertension 32:623, 1998.
34. Bursztyn M, Ginsberg G, Hammerman-Rozenberg R, Stessman Y. The siesta in the elderly: A new risk factor for mortality? Am J Hypertens 12:39A, 1999.
35. Bursztyn M, Mekler J. Subpressor dose of L-NAME unmasks hypertensive effect of insulin. Am J Hypertens 13:82A, 2000.
36. Bursztyn M, Flyvbjerg A, Mekler J, Raz I. Insulin-like growth factor I levels determine atrophy or hypertrophy in chronic renal ischemia. Am J Hypertens 13:283A, 2000.
37. Bursztyn M, Mekler J. L-arginine prevents and reverses the hypertension produced by combining hyperinsulinemia and subpressor inhibition of nitric oxide synthase. Hypertension 36:690, 2000.
38. Bursztyn M, Mekler J. Nocturnal urination may determine dipping status: A 24-hour ambulatory blood pressure study. Hypertension 36:716, 2000.
39. Destefano AL, Gavras H, Heard N, Bursztyn, M, Manolis A, Farrer LA, Baldwin CT, Gavras I, Schwartz F. Maternal influence on the inheritance of hypertension. Hypertension 36:718, 2000.
40. Bursztyn M, Perk G, Stessman J. Gender difference in the effect of heart rate on mortality. Japan J Cardiovasc Dis Prev 36(Suppl):106, 2001.
41. Perk G, Mekler J, Bursztyn M. Ambulatory pulse pressure a sleep independent variable. Am J Hypertens 15:81A, 2002.
42. Bursztyn M, Motro M, Grossman E, Shemesh J. Mild renal failure accelerates coronary artery calcifications in hypertensive subjects: Protective role of nifedipine? 14th Annual Meeting of the Mediterranean Association of Cardiology and Cardiac Surgery. October 9-12 2002, Rhodos, Greece.
43. Ben-Dov IZ, Perk G, Ben-Arie L, Mekler L, Bursztyn M. Pulse pressure is more susceptible to the white coat effect than systolic blood pressure: observations from real-life ambulatory blood pressure monitoring[abstract]. Am J Hypertens 2003;16:30A.
44. Bursztyn M, Motro M, Grossman E, Shemesh J. Renal dysfunction enhances, and nifedipine retards coronary artery calcifications in high risk hypertensives. Am J Hypertens 2003;16:13A.
45. Ben-Dov I, Ben-Arie L, Mekler J, Bursztyn M. Sleep-induced systolic blood pressure dipping is reproducible in real life ambulatory blood pressure monitoring. J Hypertens 21(Suppl. 4):S228, 2003.
46. Ben-Dov I, Ben-Arie L, Mekler J, Bursztyn M. Sleep-induced systolic blood pressure dipping is reproducible in real life ambulatory blood pressure monitoring. Hypertension 42:439, 2003.
47. Khamaisi M, Keynan S, Bursztyn M, Dahan R, Raz I. Nitric oxide production in the subacute phase in diabetic rats. Diabetes 52(suppl 1); A187, 2003.
48. Leibowitz D, Planer D, Barak V, Ben-Ivgi F, Bursztyn M. Tumor necrosis factor and interleukin-6 levels in hypertensive patients with and without left ventricular hypertrophy. J Hypertens 22(suppl.1):p582, 2004.
49. Ben-Dov I, Ben-Arie L, Mekler J, Bursztyn M. Blood pressure dipping is reproducible in real life practice. J Hypertens 22(suppl.1):p488, 2004
50. Bursztyn M, Motro M, Grossman E, Shemesh J. Mild renal dysfunction accelerates coronary artery calcification in hypertensive subjects. reproducible in real life practice. J Hypertens 22(suppl.1):op135, 2004